Search

everythinglearnresearchcommunity

for

Search:↓

Most trichological shampoo ingredients lack strong evidence for effectiveness against hair loss.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.

Use steroid creams without parabens and educate on hair transplant techniques to improve cosmetic surgery outcomes.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Direct-to-consumer teledermatology is growing fast but raises concerns about quality of care and doctor-patient relationships.

The conclusion is that hair supplement ingredients may be unsafe and should be disclosed and proven safe before use.

The conclusion is that dermatologists need to improve prescription practices to reduce errors and drug interaction risks.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Most men with hair loss worry, try self-treatments, and delay doctor visits due to cost, uncertainty, and embarrassment.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The conclusion is that pharmacists are important in helping women choose the right skin care treatments.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

Online skin care companies offer easy access to treatments but may have ethical issues like confirming patient identity, prescribing unproven therapies, and not fully explaining medication side effects. They should prioritize patient care over profit.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Pharmacists play a key role in helping patients use over-the-counter products correctly, including those for hair regrowth and smoking cessation.

The letter concludes that the aesthetics sector needs better regulation and higher-level training to ensure patient safety.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.